Gilead Sciences
Risk Level:
Summary:
Gilead Sciences does not protect its employees from viewpoint discrimination, but it does support the Equality Act. Gilead corporately denounced state legislative efforts to revise their own electoral processes while funding employee travels out of state to get an abortion. Gilead Sciences also partnered with the Human Rights Campaign (HRC). However, Gilead does discriminate against religious charities. Gilead has not ended any business relationships based on viewpoints or beliefs. For these reasons, Gilead Sciences receives a "Medium Risk" rating.
Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Gilead Sciences has not publicly terminated business relationships due to religious beliefs or political views. The company received a score of 100 on the Corporate Equality Index from the HRC. Among other requirements, this means Gilead has pledged to vet vendors based on LGBTQ policies (1).
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Gilead Science only funds organizations related to medical, scientific, and patient community support (1). It does not discriminate against religious organizations.
Employment policies fail to protect against discrimination based on political affiliation/views and/or religion.
Gilead Sciences does not protect its employees against viewpoint discrimination (1).
Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.
Gilead Sciences is an advocate for the Equality Act (1). The company also spoke out against what it called “voter suppression” in various conservative states as those states amended their election laws after the pandemic (2). The letter called for boycotting events in those states and divesting business when possible.
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
All links were last accessed and all information was updated on:
March 29, 2023
Company reports are intended for educational use only. Full Disclaimer